Literature DB >> 12399222

Earlier hepatic vein transit-time measured by contrast ultrasonography reflects intrahepatic hemodynamic changes accompanying cirrhosis.

Hiroyuki Sugimoto1, Tetsuya Kaneko, Masashi Hirota, Ekmel Tezel, Akimasa Nakao.   

Abstract

BACKGROUND/AIMS: Non-invasive diagnosis of cirrhosis by transit-time analysis of an ultrasound contrast agent has been reported, even though the mechanism by which contrast arrives to the hepatic vein earlier in cirrhosis than in normal controls is unknown. The aim of this study is to assess whether the earlier appearance of contrast in the hepatic vein depends on intrahepatic or extrahepatic causes.
METHODS: There were 15 participants: six volunteers, three patients with hepatitis, and six with cirrhosis. The contrast agent was given intravenously, and transit-time analysis of the hepatic artery, portal vein and hepatic vein was performed. The time-acoustic intensity curves in the three vessels were analyzed by an image and cineloop display and quantification software package.
RESULTS: The hepatic artery and portal vein arrival times were not significantly different among the three groups. On the other hand, hepatic vein arrival times were significantly earlier in cirrhosis (median 18 seconds) compared with arrival times in hepatitis patients (median 30 seconds, P < 0.001) and in healthy volunteers (median 31 seconds, P < 0.001). These results give support to a previous pilot study and indicate that most of the time delay in hepatic vein arrival time between cirrhosis and the other groups originated from intrahepatic circulation abnormalities.
CONCLUSIONS: This study confirms that the earlier appearance of contrast in the hepatic vein observed in cirrhosis is due to intrahepatic, and not extrahepatic, hemodynamic changes. Copyright 2002 European Association for the Study of the Liver

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12399222     DOI: 10.1016/s0168-8278(02)00264-7

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  20 in total

Review 1.  [Ultrasound contrast agents].

Authors:  T Albrecht; J Hohmann
Journal:  Radiologe       Date:  2003-10       Impact factor: 0.635

2.  Doppler study of hepatic vein in cirrhotic patients: correlation with liver dysfunction and hepatic hemodynamics.

Authors:  K-C Sudhamshu; Shoiichi Matsutani; Hitoshi Maruyama; Taro Akiike; Hiromitsu Saisho
Journal:  World J Gastroenterol       Date:  2006-09-28       Impact factor: 5.742

3.  Contrast-enhanced ultrasound evaluation of hepatic microvascular changes in liver diseases.

Authors:  Francesco Ridolfi; Teresa Abbattista; Paolo Busilacchi; Eugenio Brunelli
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

Review 4.  Non-invasive assessment of portal hypertension and liver fibrosis using contrast-enhanced ultrasonography.

Authors:  Hitoshi Maruyama; Gamal Shiha; Osamu Yokosuka; Ashish Kumar; Barjesh Chander Sharma; Alaa Ibrahim; Vivek Saraswat; Cosmas Rinaldi A Lesmana; Masao Omata
Journal:  Hepatol Int       Date:  2015-12-22       Impact factor: 6.047

5.  Diagnosis of liver cirrhosis with contrast-enhanced ultrasound.

Authors:  Guang-Jian Liu; Ming-De Lu
Journal:  World J Radiol       Date:  2010-01-28

6.  Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C.

Authors:  A K P Lim; S D Taylor-Robinson; N Patel; R J Eckersley; R D Goldin; G Hamilton; G R Foster; H C Thomas; D O Cosgrove; M J K Blomley
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

7.  Contrast-enhanced ultrasound for quantitative assessment of portal pressure in canine liver fibrosis.

Authors:  Lin Zhai; Lan-Yan Qiu; Yuan Zu; Yan Yan; Xiao-Zhuan Ren; Jun-Feng Zhao; Yu-Jiang Liu; Ji-Bin Liu; Lin-Xue Qian
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

8.  Diagnosis of liver cirrhosis by transit-time analysis at contrast-enhanced ultrasonography.

Authors:  T Abbattista; F Ridolfi; E Ciabattoni; F Marini; E Bendia; E Brunelli; P Busilacchi
Journal:  Radiol Med       Date:  2008-06-27       Impact factor: 3.469

9.  Liver fibrosis staging with contrast-enhanced ultrasonography: prospective multicenter study compared with METAVIR scoring.

Authors:  F Staub; C Tournoux-Facon; J Roumy; C Chaigneau; M Morichaut-Beauchant; P Levillain; C Prevost; C Aubé; J Lebigot; F Oberti; J B Galtier; H Laumonier; H Trillaud; P H Bernard; J F Blanc; S Sironneau; F Machet; J Drouillard; V de Ledinghen; P Couzigou; P Foucher; L Castéra; F Tranquard; Y Bacq; L d'Altéroche; P Ingrand; J P Tasu
Journal:  Eur Radiol       Date:  2009-03-04       Impact factor: 5.315

10.  Hepatic vein transit time of second-generation ultrasound contrast agent: new tool in the assessment of portal hypertension.

Authors:  Siciliani Luisa; Giovanna Vitale; Anna Rita Sorbo; Pompili Maurizio; Rapaccini Gian Lodovico
Journal:  J Ultrasound       Date:  2016-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.